Related Experiment Video

Updated: Sep 20, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

[Genome-wide scanning for susceptibility genes in researches on six HLA-associated diseases]

Ming-min Gu1, Zhu-gang Wang, Wei Huang

  • 1Department of Medical Genetics, Shanghai Second Medical University, Shanghai, 200025 PR China. mingmingu@hotmail.com

Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics
|August 7, 2003
PubMed

Insights

This review analyzes human leucocytic antigen (HLA)-associated diseases like ankylosing spondylitis and rheumatoid arthritis. It compares whole-genome scan findings for susceptibility genes and proposes solutions for challenges in genetic research.

Area of Science:

  • Immunogenetics
  • Human Genetics
  • Autoimmune Diseases

Context:

  • Six major human leucocytic antigen (HLA)-associated diseases were selected for review: ankylosing spondylitis, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, type 1 diabetes mellitus, and psoriasis.
  • These conditions share genetic links, particularly within the HLA complex, a critical region for immune system regulation.
  • Understanding these shared genetic underpinnings is crucial for advancing research into autoimmune and inflammatory disorders.

Purpose:

  • To analyze and compare the characteristics of six HLA-associated diseases based on whole-genome scan data.
  • To identify common patterns and variations in susceptibility genes or loci across these diverse conditions.
  • To propose potential strategies for addressing existing challenges in the genetic analysis of these diseases.

Summary:

  • Whole-genome scans for ankylosing spondylitis, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, type 1 diabetes mellitus, and psoriasis were analyzed.
  • Key genetic susceptibility loci and their characteristics were compared across the selected HLA-associated diseases.
  • The review highlights commonalities and differences in genetic risk factors, providing a foundation for further research.

Impact:

  • Provides a comparative overview of genetic findings for six significant HLA-associated diseases.
  • Identifies potential areas for improved genetic association studies and therapeutic target discovery.
  • Offers insights into the complex genetic architecture of immune-mediated diseases, potentially guiding future research directions.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...